As of Jun 29, 2018 WUXI BIOLOGICS CAYMAN INC ORDINARY SHARE (OTCMKTS:WXIBF) Shorts Reduced By 90.39%

June 29, 2018 - By Heather Owens

WUXI BIOLOGICS CAYMAN INC ORDINARY SHARE (OTCMKTS:WXIBF) registered a decrease of 90.39% in shorted shares. In June was issued WXIBF’s total 116,000 shorted shares by FINRA. Previously was reported down change of 90.39% from 1.21M shares. Former WXIBF’s position will need 13 days to restore. It has 9,100 average volume.

At traded at $12 lastly.Since June 29, 2017 it’s 0.00% down thus . Cayman Inc underperformed by 12.57% the S&P 500.

WuXi Biologics Inc., an investment holding company, provides integrated biologics outsourcing services worldwide.The company has $14.00 billion market cap. The firm offers services for the discovery, development, and manufacture of biologics, such as monoclonal antibodies, recombinant therapeutic proteins, fusion proteins, vaccines, blood and blood components, allergenics, somatic cells, gene therapy, and tissues.352.94 is the P/E ratio. It serves pharmaceutical and biotechnology companies.

Receive News & Ratings Via Email - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings with our FREE daily email newsletter.